Orion Sponsor Holdings, LLC - May 17, 2023 Form 4 Insider Report for Orion Biotech Opportunities Corp. (ORIA)

Role
10%+ Owner
Signature
Orion Sponsor Holdings, LLC, By: /s/ Marcello Liguori, Vice President
Stock symbol
ORIA
Transactions as of
May 17, 2023
Transactions value $
$0
Form type
4
Date filed
5/18/2023, 04:05 PM
Previous filing
Jun 30, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ORIA Class B ordinary shares Disposed to Issuer -4.88M -100% 1 May 17, 2023 Class A ordinary shares 4.88M Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Orion Sponsor Holdings, LLC is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 On April 21, 2023, the Issuer announced that it will not consummate an initial business combination within the time period required. Pursuant to the Issuer's Amended and Restated Memorandum and Articles of Association (the "Articles") and in connection with the winding up of the Issuer, the Class B ordinary shares, par value $0.0001, held by Orion Sponsor Holdings, LLC (the "Sponsor") were surrendered for no compensation on May 17, 2023.
F2 This Form 4 is being filed by the Sponsor. The Class B ordinary shares are held in the name of the Sponsor. The Sponsor is managed by a board of managers comprised of James Huang, John Phelan and Robert Platek, who control the Sponsor. Accordingly, Messrs. Huang, Phelan and Platek have voting and investment discretion with respect to the securities held by the Sponsor, and may be deemed to have beneficial ownership of the securities held directly by the Sponsor. Each of Messrs. Huang, Phelan and Platek disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.

Remarks:

After giving effect to the Issuer's delisting and deregistration, the Reporting Persons will no longer be subject to Section 16 reporting obligations.